2 options
Pharmaceutical Pricing : Does Federal R&D Support Justify Federal Review of Prices?
- Format:
- Book
- Government document
- Author/Creator:
- Library of Congress. Congressional Research Service.
- Language:
- English
- Subjects (All):
- Business.
- Drugs.
- Pharmaceutical industry.
- Physical Description:
- 1 online resource (33 pages) : digital, PDF file
- monochrome
- Place of Publication:
- [Place of publication not identified] : [publisher not identified], 1993.
- System Details:
- System requirements: PDF reader software.
- text file
- Summary:
- Explores arguments for price regulation of drugs developed with Federal aid in the form of R&D support or technology transfers. Reviews efforts to moderate the prices of these pharmaceuticals through Congressional action and "price clause" enforcement by the NIH's Patent Policy Board. Examines relevant statutes and regulations, legislative history, and pharmaceutical industry's viewpoint.
- Notes:
- CRS Report.
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC.
- Other Format:
- Microfiche version: Library of Congress. Congressional Research Service. Pharmaceutical Pricing
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.